BPC-157 is a research compound derived from gastric protective protein, not FDA or EMA approved for therapeutic indications
Mechanistically, these changes appear to coincide with elevated NAD+ and activation of metabolic gene programs consistent with increased energy expenditure

You may also like Product Description BPC-157 Peptide | Buy BPC-157 UK | Research Use Only BPC-157 also known as Body Protection Compound 157, Stable Gastric Pentadecapeptide BPC 157, and PL-10 is a synthetic 15-amino acid peptide (GEPPPGKPADDAGLV, MW 1,419 Da) derived from a partial sequence of the endogenous body protection compound first isolated from human gastric juice, with no sequence homology to any other known peptide, that in pre-clinical research demonstrates a uniquely broad tissue-protective and repair-promoting profile spanning tendon, ligament, muscle, bone, and gastrointestinal tissue acting through a coordinated network of angiogenic, cytoprotective, and fibroblast-signalling mechanisms including VEGFR2/Akt/eNOS, GHR/JAK2, and HO-1 antioxidant pathways making it the most extensively studied gastric-derived peptide in pre-clinical tissue repair and cytoprotection research
DripSuites offers IV drips for every lifestyle
Pairing it with Vitamin C further boosts how well your body uses it
For those already Pregnant: Oxidative damage is linked to a host of pregnancy risks including preeclampsia, IUGR, gestational diabetes and more